ZLAB vs RARE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

ZLAB

61.1
AI Score
VS
ZLAB Wins

RARE

38.9
AI Score

Investment Advisor Scores

ZLAB

61score
Recommendation
BUY

RARE

39score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric ZLAB RARE Winner
Forward P/E 0 0 Tie
PEG Ratio 0 -0.24 Tie
Revenue Growth -3.3% 28.1% RARE
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 61.1/100 38.9/100 ZLAB
Profit Margin -41.9% -81.7% ZLAB
Beta 1.00 1.00 Tie
AI Recommendation BUY AVOID NEW MONEY ZLAB

Relative Price Performance (Last 90 Days)

ZLAB 1M: -8.4% · 3M: +23.0% RARE 1M: +2.0% · 3M: -41.1%

Current Technical Phase

ZLAB

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 47.6 · Price: $24.20

RARE

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 49

RSI (14): 49.4 · Price: $15.92

Fundamentals Snapshot

Metric ZLAB RARE
Market Cap — —
Forward P/E -11.5 70.6
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% 0.3%
Gross Margin 0.0% -0.2%
Operating Margin -0.7% -0.4%
EPS -1.70 -5.82
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, ZLAB is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.